Preclinical and Clinical Evaluation of Intraductally Administered Agents in Early Breast Cancer
Vered Stearns(Johns Hopkins University), Saraswati Sukumar(Johns Hopkins University), Penny Powers(Parkland Health & Hospital System), Karineh Tarpinian(Indiana University Health), Lisa K. Jacobs(Johns Hopkins University), Scott L. Kominsky(Johns Hopkins University), Takahiro Yoshida(Osaka Prefecture University), Theodore N. Tsangaris(Georgetown University), Regina J. Brown(Johns Hopkins University), Zhe Zhang(Peking University), Tsuyoshi Mori(Johns Hopkins University), Julie R. Lange(Johns Hopkins Medicine), Stacie C. Jeter(Johns Hopkins University), Nagi F. Khouri(Johns Hopkins University), David L. Huso(Johns Hopkins University), Edward Gabrielson(Bloomberg (United States)), Michelle A. Rudek(Dana-Farber Cancer Institute)
Cited by 77
Related Papers
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment
|JNCI Journal of the National Cancer Institute|2005|947